Samrat Pharmachem Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 76.34 | 71.10 | 63.67 |
| Operating Expense | 75.53 | 71.08 | 59.49 |
| Net Profit | -0.23 | -0.40 | 2.78 |
| Net Profit Margin | -0.30 | -0.56 | 4.37 |
| Earning Per Share | -0.74 | -1.29 | 9.01 |
| EBIDTA | 0.38 | 0.07 | 3.93 |
| Effective Tax Rate | TBA | 450 | 21.05 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 76.34 |
| Operating Expense | 75.53 |
| Net Profit | -0.23 |
| Net Profit Margin | -0.30 |
| Earning Per Share | -0.74 |
| EBIDTA | 0.38 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 285.86 | 281.58 | 310.65 |
| Operating Expenses Annual | 275.62 | 279.11 | 286.72 |
| Operating Profit Annual | 11.21 | 3.85 | 24.41 |
| Interest Annual | 0.67 | 0.69 | 1.23 |
| Depreciation | 0.65 | 0.65 | 0.64 |
| Net Profit Annual | 7.11 | 2.16 | 16.63 |
| Tax Annual | 2.77 | 0.36 | 5.90 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 285.86 |
| Operating Expenses Annual | 275.62 |
| Operating Profit Annual | 11.21 |
| Interest Annual | 0.67 |
| Depreciation | 0.65 |
| Net Profit Annual | 7.11 |
| Tax Annual | 2.77 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 9.67 | 11.86 | 14.71 |
| Cash Flow from Operations | -10.09 | 9.41 | -9.44 |
| Cash Flow from Investing | TBA | -0.41 | -3 |
| Cash Flow from Financing | 0.48 | -11.20 | 9.60 |
| Cash Flow at the End | 0.05 | 9.67 | 11.86 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 9.67 |
| Cash Flow from Operations | -10.09 |
| Cash Flow from Investing | TBA |
| Cash Flow from Financing | 0.48 |
| Cash Flow at the End | 0.05 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 3.92 | 1.01 | 7.85 |
| PBIT Margin (%) | 3.69 | 0.78 | 7.65 |
| PBT Margin (%) | -1.82 | -0.35 | 1.43 |
| Net PROFIT Margin (%) | 2.49 | 0.77 | 5.35 |
| Return On Networth / Equity (%) | 10.39 | 1.98 | 30.25 |
| Return On Networth /Employed (%) | 13.60 | 2.83 | 34.91 |
| Return On Assets (%) | 9.15 | 2.78 | 24.41 |
| Total Debt / Equity (X) | 0.13 | 0.21 | 0.24 |
| Asset Turnover Ratio (%) | 3.68 | 3.63 | 4.56 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 3.92 |
| PBIT Margin (%) | 3.69 |
| PBT Margin (%) | -1.82 |
| Net PROFIT Margin (%) | 2.49 |
| Return On Networth / Equity (%) | 10.39 |
| Return On Networth /Employed (%) | 13.60 |
| Return On Assets (%) | 9.15 |
| Total Debt / Equity (X) | 0.13 |
| Asset Turnover Ratio (%) | 3.68 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 10.48 | 10.72 | 10.70 |
| Total Current Assets Annual | 103.36 | 102.57 | 99.05 |
| Non Current Assets Annual | 18.13 | 19.17 | 17.54 |
| Total Shareholders Funds Annual | 71.80 | 65.00 | 63.14 |
| Total Assets Annual | 121.49 | 121.74 | 116.59 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 10.48 |
| Total Current Assets Annual | 103.36 |
| Non Current Assets Annual | 18.13 |
| Total Shareholders Funds Annual | 71.80 |
| Total Assets Annual | 121.49 |
No Data Availabe
